精锋医疗-B(02675)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02675 精锋医疗-B

休市中 11-13 16:08:17

27.340

-0.540

-1.94%

最高27.360	最低26.220	成交量41.00万
今开27.220	昨收27.880	日振幅4.09%
总市值106.08亿	流通市值88.58亿	总股本3.88亿
成交额1,090万	换手率0.13%	流通股本3.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02675","market":"HK","secType":"STK","nameCN":"精锋医疗-B","latestPrice":27.34,"timestamp":1794557297007,"preClose":27.88,"halted":0,"volume":410000,"delay":0,"changeRate":-0.019368723098995667,"floatShares":324000000,"shares":388000000,"eps":-0.24613,"marketStatus":"休市中","change":-0.54,"latestTime":"11-13 16:08:17","open":27.22,"high":27.36,"low":26.22,"amount":10897876,"amplitude":0.04089,"askPrice":27.88,"askSize":100,"bidPrice":27.34,"bidSize":74600,"shortable":3,"etf":0,"ttmEps":-0.057811,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":7,"adr":0,"listingDate":1767801600000,"exchange":"SEHK","adjPreClose":27.88,"openAndCloseTimeList":[[1794533400000,1794542400000],[1794546000000,1794556800000]],"volumeRatio":2.120766,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02675","defaultTab":"news","newsList":[{"id":"1119444788","title":"精锋医疗-B：王建辰增持，好仓比例升至38.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119444788","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119444788?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:32","pubTimestamp":1794216744,"startTime":"0","endTime":"0","summary":"精锋医疗-B（02675）于2026年11月3日在联交所场内根据回购授权回购H股20.00万股并作为库藏股，成交均价每股29.4895港元，涉资约589.79万港元。由于王建辰控制公司三分之一或以上投票权，他被视为对公司库藏股拥有权益，该回购使其被计入的好仓股数增加。该回购通过联交所公开市场撮合进行，属二级市场交易。王建辰此次增持前持有精锋医疗-B好仓1.25亿，占比37.99%；增持后持股量为1.25亿，好仓比例升至38.05%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191012199","title":"精锋医疗-B：高元倩增持，好仓比例升至38.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191012199","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191012199?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:24","pubTimestamp":1794216284,"startTime":"0","endTime":"0","summary":"高元倩于2026年11月3日所涉权益变动来自公司回购：精锋医疗-B（02675）依据回购授权在联交所场内以每股均价29.4895港元回购股份20.00万股，涉资约589.79万港元；该笔为场内主动交易，即在二级市场直接买卖股份，回购股份当日作为库藏股持有。高元倩此次增持前持有精锋医疗-B好仓1.25亿，占比37.99%；增持后持股量为1.25亿，好仓比例升至38.05%。原文链接：Hong Kong Exchanges and Clearing Limited。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149979760","title":"精锋医疗-B2026年10月股份变动月报：总股本保持不变并回购218万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149979760","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149979760?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:39","pubTimestamp":1793867983,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年11月5日披露了截至2026年10月31日的股份变动月报表。公告显示，截至本报告期末，公司注册股本为人民币391,880,500元，较上月保持不变。其中，H股注册股本327,761,248元，其余未上市普通股注册股本64,119,252元，面值均为人民币1元。公司在本月内无新增发行及注销股份，整体股本规模维持不变。然而，公司通过多次回购完成了2,180,000股H股的购回，回购完成后，库存H股由2,263,400股增至4,443,400股，对应已发行在外H股则从325,497,848股减至323,317,848股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191194751","title":"精锋医疗-B回购20万股股份，涉资约589.79万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191194751","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191194751?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:51","pubTimestamp":1793703116,"startTime":"0","endTime":"0","summary":"根据公告，2026年11月3日公司于港交所回购股份20万股，占2026年10月30日公司已发行股本3.2332亿股的约0.0619%，每股价格介乎每股28.64港元至30港元，合计耗资约589.79万港元。本次交易完成后，公司已发行股本减少至3.2312亿股，库藏股增至464.34万股，整体已发行股本总数仍为3.2776亿股。公司已于2026年6月25日获股东大会通过最多可回购3,261.4504万股股份。截至本次公告，已回购股份合计达302.72万股，占当时公司已发行股本的约0.9282%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B回购20万股股份，涉资约589.79万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132721480","title":"精锋医疗-B：高元倩增持，好仓比例升至37.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132721480","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132721480?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:41","pubTimestamp":1793698907,"startTime":"0","endTime":"0","summary":"精锋医疗-B（02675）：公司根据回购授权于2026年10月29日在联交所场内以每股均价31.3779港元回购精锋医疗-B股份8.55万股并作为库藏股持有，涉资约268.28万港元。鉴于高元倩对公司表决权控制达三分之一或以上，被视为对该等库藏股拥有权益，其好仓因此增加；该笔为场内交易，透过联交所公开市场撮合成交，属二级市场直接买卖。高元倩此次增持前持有精锋医疗-B好仓1.24亿，占比37.93%；增持后持股量为1.24亿，好仓比例升至37.95%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105089927","title":"精锋医疗-B：高元倩增持，好仓比例升至37.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105089927","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105089927?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:35","pubTimestamp":1793698530,"startTime":"0","endTime":"0","summary":"精锋医疗-B根据回购授权于2026年10月30日在联交所场内以每股均价31.2704港元回购H股11.92万股，涉资约372.74万港元。高元倩此次增持前持有精锋医疗-B好仓1.24亿，占比37.95%；增持后持股量为1.25亿，好仓比例升至37.99%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182864920","title":"精锋医疗-B：王建辰增持，好仓比例升至37.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182864920","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182864920?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:32","pubTimestamp":1793698323,"startTime":"0","endTime":"0","summary":"2026年10月29日，公司在联交所场内按每股均价31.3779港元回购精锋医疗-B股份8.55万股，涉资约268.28万港元。该等股份依据回购授权回购并作为库藏股持有。因王建辰控制公司三分之一或以上投票权，按SFO被视为对上述库藏股拥有权益。王建辰此次增持前持有精锋医疗-B好仓1.24亿，占比37.93%；增持后持股量为1.24亿，好仓比例升至37.95%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112364840","title":"精锋医疗-B：王建辰增持，好仓比例升至37.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112364840","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112364840?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:13","pubTimestamp":1793697236,"startTime":"0","endTime":"0","summary":"2026年10月30日，精锋医疗-B（02675）依据回购授权在联交所场内以每股均价31.2704港元回购11.92万股H股并作为库藏股，涉资约372.74万港元。由于王建辰对公司拥有三分之一或以上的表决权，被视为对上述库藏股拥有权益，致其好仓股份数上升；该笔属场内主动交易，经联交所公开市场撮合成交，属于二级市场直接买卖。王建辰此次增持前持有精锋医疗-B好仓1.24亿，占比37.95%；增持后持股量为1.25亿，好仓比例升至37.99%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193426671","title":"精锋医疗-B 2025年度补充披露：固定收益理财产品贡献最高3.27%年化回报","url":"https://stock-news.laohu8.com/highlight/detail?id=1193426671","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193426671?lang=zh_cn&edition=full","pubTime":"2026-11-02 18:02","pubTimestamp":1793613763,"startTime":"0","endTime":"0","summary":"精锋医疗-B针对截至2025年12月31日止年度的年报发布补充公告，披露其所持有的重大理财产品信息。根据公告，公司使用自有资金认购多项中国持牌银行提供的固定收益类理财产品，资金不涉及全球发售所得款项。相关认购日期集中于2024年11月4日至2025年6月18日，并于2025年4月1日及2025年7月22日进行了协议更新。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B 2025年度补充披露：固定收益理财产品贡献最高3.27%年化回报","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177374531","title":"精锋医疗-B于10月30日回购119,200股，涉资约372.74万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177374531","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177374531?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:50","pubTimestamp":1793357450,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年10月30日发布公告，披露公司当日于香港联交所场内回购119,200股H股，占当日公司现有已发行股份约0.0369%。每股回购价格介乎每股30.56港元至31.94港元，合计支付约372.74万港元。公司购回授权的决议于2026年6月25日获批，获准回购股份总数为32,614,504股，截至目前已回购2,827,200股。公司表示，已严格遵守香港联交所证券上市规则及相关法律法规，履行了全部必要的审批和程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B于10月30日回购119,200股，涉资约372.74万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679297050","title":"精锋医疗-B(02675.HK)10月30日斥资约372.74万港元回购11.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679297050","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679297050?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:48","pubTimestamp":1793357319,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02675","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192967325","title":"精锋医疗-B：王建辰增持，好仓比例升至37.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192967325","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192967325?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:41","pubTimestamp":1793353280,"startTime":"0","endTime":"0","summary":"2026年10月28日，精锋医疗-B依据回购授权在联交所场内以每股均价33.3034港元回购30.00万股，涉资约999.10万港元；该笔为场内主动交易，即在二级市场直接买卖股份。由于王建辰被视为对公司库存股拥有权益，其好仓因此增加。王建辰此次增持前持有精锋医疗-B（02675）好仓1.24亿，占比37.83%；增持后持股量为1.24亿，好仓比例升至37.93%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160254997","title":"精锋医疗-B：高元倩增持，好仓比例升至37.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160254997","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160254997?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:14","pubTimestamp":1793351642,"startTime":"0","endTime":"0","summary":"高元倩披露，精锋医疗-B（02675）根据回购授权于2026年10月28日在联交所场内按每股均价33.3034港元回购H股30.00万股，涉资约999.10万港元；相关股份作为库藏股持有，依据法规高元倩被视为对库藏股拥有权益。该回购通过联交所公开市场撮合完成，属场内主动交易，即二级市场直接买卖。高元倩此次增持前持有精锋医疗-B好仓1.24亿，占比37.83%；增持后持股量为1.24亿，好仓比例升至37.93%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199265122","title":"精锋医疗-B回购8.55万股股份，耗资约268.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199265122","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199265122?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:12","pubTimestamp":1793283136,"startTime":"0","endTime":"0","summary":"精锋医疗-B于2026年10月29日发布公告，披露在香港联交所场内回购85,500股H股股份，占当日回购前已发行股本约0.0264%。本次回购每股价格介乎30.92港元至32港元，总动用资金约268.28万港元。回购完成后，公司已发行股本变动为323,437,048股，库存股份增至4,324,200股。公司强调，此次股份回购遵守香港联合交易所有限公司的上市规则及相关法律规例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B回购8.55万股股份，耗资约268.28万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180673363","title":"精锋医疗-B回购30万股股份，总额约999.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180673363","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180673363?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:56","pubTimestamp":1793188573,"startTime":"0","endTime":"0","summary":"精锋医疗-B于2026年10月28日公告回购股份，回购数量为300,000股，占当日公司已发行股本约0.0926%。回购价格区间为每股港币32.76元至33.50元，合计涉资约999.10万港元。根据2026年6月25日通过的购回授权，精锋医疗-B可回购的股份总数为32,614,504股，目前已累计购回2,622,500股，占授权决议通过当日已发行股本约0.8041%。公司方面确认，上述购回行为已遵守相关上市规则及适用法例。公告由联席公司秘书吴梦媛签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B回购30万股股份，总额约999.10万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678462951","title":"精锋医疗-B(02675)10月28日耗资约999.1万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678462951","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678462951?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:53","pubTimestamp":1793188409,"startTime":"0","endTime":"0","summary":"智通财经APP讯，精锋医疗-B(02675)公布，2026年10月28日耗资约999.1万港元回购30万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02675","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107382103","title":"精锋医疗-B回购7.88万股，涉资约259.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107382103","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107382103?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:02","pubTimestamp":1793098944,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年10月27日在香港联交所发布翌日披露报表，公告显示公司近期进行了股份回购。本次回购价格区间为每股32.24港元至33.00港元，合计耗资2,595,578港元，折合约259.56万港元。本次回购完成后，公司已发行股本减少至323,822,548股，库藏股数增至3,938,700股，整体已发行股份总数保持327,761,248股不变。公司确认，本次回购项目已获董事会正式授权，遵守香港联合交易所有限公司证券上市规则及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B回购7.88万股，涉资约259.56万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678176504","title":"精锋医疗-B(02675)10月27日耗资约259.56万港元回购7.88万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678176504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678176504?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:59","pubTimestamp":1793098778,"startTime":"0","endTime":"0","summary":"智通财经APP讯，精锋医疗-B(02675)公布，2026年10月27日耗资约259.56万港元回购7.88万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02675","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677692190","title":"精锋医疗-B(02675.HK)10月23日耗资约178.28万港元回购5.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677692190","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677692190?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:54","pubTimestamp":1792756474,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02675","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156677781","title":"精锋医疗-B10月23日回购5.64万股，耗资约178.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156677781","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156677781?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:52","pubTimestamp":1792756327,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年10月23日公告称，公司在香港联交所回购股份共计56,400股，约占回购前已发行股本的0.0174%。本次回购的最高价为每股32港元，最低价为每股30.94港元，涉资总额1,782,764港元，相当于约178.28万港元。本次回购依托于公司于2026年6月25日通过的购回授权，该授权允许公司最多回购32,614,504股，迄今已回购的股份累计达2,243,700股。公司强调，本次股份回购严格遵守香港联交所证券上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B10月23日回购5.64万股，耗资约178.28万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgemedical.cn","stockEarnings":[{"period":"1week","weight":0.038},{"period":"1month","weight":-0.1462},{"period":"3month","weight":-0.2862},{"period":"6month","weight":-0.4575},{"period":"1year","weight":-0.3677},{"period":"ytd","weight":-0.3677}],"compareEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0278},{"period":"3month","weight":-0.0589},{"period":"6month","weight":-0.0896},{"period":"1year","weight":-0.1269},{"period":"ytd","weight":-0.0778}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市精锋医疗科技股份有限公司是一家主要从事设计、开发及制造手术机器人的中国公司。该公司的主要产品包括“精锋”多孔腔镜手术机器人、“精锋”单孔腔镜手术机器人和精锋支气管镜机器人。“精锋”多孔腔镜手术机器人是一种机器人辅助设备，用于进行微创手术（MIS），使用机器人、成像技术和数字技术，应用范围涵盖泌尿科、妇科、普外科及胸外科。“精锋”单孔腔镜手术机器人是一种机器人辅助设备，用于通过单个小切口或自然腔道进行微创手术，应用范围涵盖泌尿科、妇科及普外科。该公司在中国国内市场及海外市场开展业务。","exchange":"SEHK","name":"精锋医疗-B","nameEN":"EDGE MEDICAL-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精锋医疗-B(02675)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精锋医疗-B(02675)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精锋医疗-B,02675,精锋医疗-B股票,精锋医疗-B股票老虎,精锋医疗-B股票老虎国际,精锋医疗-B行情,精锋医疗-B股票行情,精锋医疗-B股价,精锋医疗-B股市,精锋医疗-B股票价格,精锋医疗-B股票交易,精锋医疗-B股票购买,精锋医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精锋医疗-B(02675)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精锋医疗-B(02675)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}